U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903831) titled 'Phase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis B' on Oct. 16.
Brief Summary: Study SCTA02A-A101 is designed to assess the safety, tolerability and pharmacokinetics of SCTA02A in healthy volunteers and participants with chronic hepatitis B virus infection. Eligible participants will receive study treatment in this phase 1 dose-escalation study. All treated patients will also undergo a safety follow-up period after last study drug administration.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Hepatitis B
Intervention:
BIOLOGICAL: SCTA02A
SCTA02A, an investigation...